Evofem Biosciences (EVFM) Capital Expenditures (2014 - 2026)
Evofem Biosciences' Capital Expenditures came in at $2,000 for Q1 2026, down 33.3% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Capital Expenditures (2014 - 2026) Analysis & Trends
For FY2025, Evofem Biosciences' Capital Expenditures was $5,000, down 64.3% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of -70.5% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $14,000 in FY2024 (+250.0%), $4,000 in FY2023 (-98.8%), $341,000 in FY2022 (-88.4%) and $2.94 million in FY2021 (+30.4%).
- The Q1 2026 figure represents the lowest quarterly Capital Expenditures since Q2 2023.
- The fastest year-over-year change in Capital Expenditures over five years came in Q1 2024 (growth of 366.7%), and the weakest in Q2 2023 (a decline of 99.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 70,000.00 |
| Jun 30, 2022 | 170,000.00 |
| Mar 31, 2022 | 66,000.00 |
| Dec 31, 2021 | 53,000.00 |
| Sep 30, 2021 | 597,000.00 |
| Jun 30, 2021 | 1.33 Mn |
| Mar 31, 2021 | 956,000.00 |
| Dec 31, 2020 | 1.42 Mn |
| Sep 30, 2020 | 297,000.00 |
| Jun 30, 2020 | 441,000.00 |
| Mar 31, 2020 | 95,000.00 |
| Dec 31, 2019 | 141,000.00 |
| Dec 31, 2018 | 7,000.00 |
| Mar 31, 2015 | 226,128.00 |
API Access
Evofem Biosciences Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();